Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Ares-Serono initiates comparative study of Rebif and Avonex

Oct. 7, 1999

Candidate schizophrenia gene identified through Genset-Janssen collaboration

Oct. 7, 1999

FDA approves new indication for Topamax

Oct. 6, 1999

Is depression an endocrine system disorder?

Oct. 6, 1999

CuraGen and Glaxo Wellcome complete Alzheimer's disease research program

Oct. 5, 1999

Roche confirms AD drug dropped by the wayside; two other MAO-B inhibitors remain in development

Oct. 5, 1999

Lilly and Synaptic investigate potential of 5-HT1A antagonist in nicotine withdrawal

Oct. 5, 1999

Novel monoamine reuptake inhibitors designed at ADIR, particularly useful in depression

Oct. 5, 1999

New CRF antagonists codeveloped by Janssen and Neurocrine Biosciences

Oct. 5, 1999

SUN-N4057 reduces both brain and body temperature in cat model of stroke

Oct. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...